Sort
15,842 grants matching “pancreatic cancer”
Epigenetic drivers of cancer progression
$423,649Andrew P Feinberg · Johns Hopkins University · R01 · FY2022 · CA
ELUCIDATION & MODULATION OF NATURAL KILLER CELL SIGNALING: APPLICATION IN CANCER
$423,497Michael A Caligiuri · Ohio State University · P01 · FY2010 · CA
The Development of Clinical Grade, Targeted Magnetic Nanoparticles
$423,474Ralph Weissleder · Massachusetts Institute Of Technology · U54 · FY2010 · CA
Mechanisms of immunotherapy response and resistance in pancreatic ductal adenocarcinoma
$423,354Ingunn Margarete Stromnes · University Of Minnesota · R01 · FY2022 · CA
Mechanisms of immunotherapy response and resistance in pancreatic ductal adenocarcinoma
$423,354Ingunn Margarete Stromnes · University Of Minnesota · R01 · FY2023 · CA
Role of HSP70 in Pancreatic Diseases
$423,276Sundaram Ramakrishnan · University Of Miami School Of Medicine · R01 · FY2020 · CA
Elucidating the mechanism of Ga13 mediated tumor suppression in pancreatic cancer
$423,251Mario Shields · Northwestern University At Chicago · R01 · FY2023 · CA
Isoprenylcysteine Carboxyl Methyltransferase (ICMT) as a Target in NRAS Driven Melanoma - Resubmission - 1
$423,242Mark Reid Philips · New York University School Of Medicine · R01 · FY2019 · CA
Isoprenylcysteine Carboxyl Methyltransferase (ICMT) as a Target in NRAS Driven Melanoma - Resubmission - 1
$423,242Mark Reid Philips · New York University School Of Medicine · R01 · FY2020 · CA
Epigenetic drivers of cancer progression
$423,127Andrew P Feinberg · Johns Hopkins University · R01 · FY2019 · CA
Project 2: Immune signals promoting pancreas cancer stemness and progression
$423,030Steven E Artandi · Stanford University · P01 · FY2025 · CA
Project 3 â Stromal derived IL-6/STAT3 signaling in the development and progression of PDAC
$422,885Michael C Ostrowski · Medical University Of South Carolina · P01 · FY2025 · CA
Frontiers in Bone Metastatic Models for Prostate Cancer
$422,874Leslie Ann Caromile · University Of Connecticut Sch Of Med/Dnt · R21 · FY2024 · CA
Targeted Radiation Therapy for Pancreatic Cancer
$422,866Surinder Kumar Batra · University Of Nebraska Medical Center · R01 · FY2019 · CA
Epigenetic Drivers of Cancer Progression
$422,743Andrew P Feinberg · Johns Hopkins University · R01 · FY2017 · CA
MECHANISMS OF SIGNAL TRANSDUCTION BY RAS PROTEINS
$422,708Dafna Bar-Sagi · State University New York Stony Brook · R37 · FY2006 · CA
METEOR-BioLogical Specimen Translation (METEOR-BLST)
$422,630Michael Benjamin Major · Washington University · U54 · FY2023 · CA
Transport Oncophysics Core
$422,589Haifa Shen · Methodist Hospital Research Institute · U54 · FY2020 · CA
Role of ALK4 in Regulating Receptor Trafficking and Pancreatic Cancer Biology
$422,572Gerard C Blobe · Duke University · R01 · FY2020 · CA
Label-Free Nanopore Biosensor for Rapid, Ultrasensitive, and Multiplex Detection of Protease Activities
$422,520Xiyun Guan · Illinois Institute Of Technology · R15 · FY2017 · GM
Discovery of First-in-class WDR5 PROTACs as a Novel Therapeutic Strategy for MLL-rearranged Leukemias
$422,496Jian Jin · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · CA
Mechanism of APE1 in DNA damage response
$422,451Shan Yan · University Of North Carolina Charlotte · R01 · FY2021 · CA
Exploiting Integrin Signaling to Overcome Resistance to Immunotherapy
$422,422David G Denardo · Washington University · R01 · FY2024 · CA
SAMBAI-Columbia
$422,413Gary W Miller · Columbia University Health Sciences · OT2 · FY2024 · CA
Chemophototherapy with Porphyrin-phospholipid Liposomes Permeabilized by Red Light
$422,405Jonathan F Lovell · State University Of New York At Buffalo · R01 · FY2018 · EB